TLR2 and age-related diseases: Potential effects of Arg753Gln and Arg677Trp polymorphisms in acute myocardial infarction

Rejuvenation Research

Volumn 11, Issue 2, 2008, Pages 293-296

  Balistreri, Carmela Rita ^a   Candore, Guiseppina ^a   Mirabile, Monica ^a   Lio, Domenico ^a   Caimi, Gregorio ^a   Incalcaterra, Egle ^a   Caruso, Marco ^a   Hoffmann, Enrico ^a   Caruso, Calogero ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLYCINE; TOLL LIKE RECEPTOR 2; TRYPTOPHAN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC RISK; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; PHARMACOGENOMICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGING; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; ITALY; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 2;

EID: 42649118787     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2008.0666     Document Type: Article

References (21)

1. Licastro F, Candore G, Lio D, Porcellini E, Colonna-Romano G, Franceschi C, Caruso C. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing 2005;2:8.
2. Caruso C, Candore G, Colonna-Romano G, Lio D, Franceschi C. Inflammation and life-span. Science 2005;307:208-209.
3. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 2006;80:219-227.
4. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007;128:92-105.
5. Salvioli S, Olivieri F, Marchegiani F, Cardelli M, Santoro A, Bellavista E, Mishto M, Invidia L, Capri M, Valensin S, Sevini F, Cevenini E, Celani L, Lescai F, Gonos E, Caruso C, Paolisso G, De Benedictis G, Monti D, Franceschi C. Genes, ageing and longevity in humans: problems, advantages and perspectives. Free Radic Res 2006;40:1303-1323.
6. Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-Romano G, Grimaldi MP, Listi F, Nuzzo D, Lio D, Caruso C. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007;128:83-91.
7. Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol 2007;19:3-10.
8. Oude Nijhuis MM, van Keulen JK, Pasterkamp G, Quax PH, de Kleijn DP. Activation of the innate immune system in atherosclerotic disease. Curr Pharm Des 2007;13:983-994.
9. Li H, Sun B. Toll-like receptor 4 in atherosclerosis. J Cell Mol Med 2007;11:88-95.
10. Bjorkbacka H. Multiple roles of Toll-like receptor signaling in atherosclerosis. Curr Opin Lipidol 2006;17:527-533.
11. Michelsen KS, Doherty TM, Shah PK, Arditi M. TLR signaling: an emerging bridge from innate immunity to atherogenesis. J Immunol 2004;173:5901-5907.
12. Pasterkamp G, Van Keulen JK, De Kleijn DP. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur J Clin Invest 2004;34:328-334.
13. Yang IA, Holloway JW, Ye S. TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis. Atherosclerosis 2003;170:187-190.
14. Reismann P, Lichy C, Rudofsky G, Humpert PM, Genius J, Si TD, Dorfer C, Grau AJ, Hamann A, Hacke W, Nawroth PP, Bierhaus A. Lack of association between polymorphisms of the toll-like receptor 4 gene and cerebral ischemia. J Neurol 2004;251:853-858.
15. Zee RY, Hegener HH, Gould J, Ridker PM. Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis. Stroke 2005;36:154-157.
16. Balistreri CR, Candore G, Colonna-Romano G, Lio D, Caruso M, Hoffmann E, Franceschi C, Caruso C. Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 2004;292:2339-2340.
17. Bochud PY, Hawn TR, Aderem A. Cutting edge: a toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol 2003;170:3451-3454.
18. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994;330:1041-1046.
19. Mullaly SC, Kubes P. Toll gates and traffic arteries: from endothelial TLR2 to atherosclerosis. Circ Res 2004;95:657-659.
20. Candore G, Balistreri CR, Caruso M, Grimaldi MP, Incalcaterra E, Listì F, Vasto S, Caruso C. Pharmacogenomics: a tool to prevent and cure coronary heart disease. Curr Pharm Des 2007;13:3726-3734.
21. Grimaldi MP, Vasto S, Balistreri CR, Di Carlo D, Caruso M, Incalcaterra E, et al. Genetics of inflammation in age-related atherosclerosis: its relevance to pharmacogenomics. Ann NY Acad Sci 2007;1100:123-131.